Can Serum Cystatin C predict long-term survival in cardiac surgery patients?

Renal dysfunction is a risk factor for morbidity and mortality in cardiac surgery patients. Serum Cystatin C (sCysC) is a well-recognized marker of early renal dysfunction but few reports evaluate its prognostic cardio-vascular role. The aim of the study is to consider the prognostic value of sCysC...

Descripción completa

Detalles Bibliográficos
Autores principales: Rovella, Valentina, Marrone, Giulia, Dessì, Mariarita, Ferrannini, Michele, Toschi, Nicola, Pellegrino, Antonio, Casasco, Maurizio, Di Daniele, Nicola, Noce, Annalisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892696/
https://www.ncbi.nlm.nih.gov/pubmed/29615540
http://dx.doi.org/10.18632/aging.101403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892696/
https://www.ncbi.nlm.nih.gov/pubmed/29615540
http://dx.doi.org/10.18632/aging.101403

Ejemplares similares